Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 20 04:00PM ET
365.96
Dollar change
-0.52
Percentage change
-0.14
%
IndexS&P 500 P/E13.34 EPS (ttm)27.43 Insider Own0.21% Shs Outstand231.93M Perf Week-4.05%
Market Cap84.75B Forward P/E10.48 EPS next Y34.91 Insider Trans-8.03% Shs Float231.44M Perf Month-7.93%
Income6.42B PEG1.48 EPS next Q3.98 Inst Own90.42% Short Float1.22% Perf Quarter-31.46%
Sales174.01B P/S0.49 EPS this Y0.12% Inst Trans-1.47% Short Ratio1.47 Perf Half Y-32.44%
Book/sh188.74 P/B1.94 EPS next Y5.21% ROA5.65% Short Interest2.82M Perf Year-20.31%
Cash/sh- P/C- EPS next 5Y9.01% ROE15.62% 52W Range362.21 - 567.26 Perf YTD-22.39%
Dividend Est.6.33 (1.73%) P/FCF97.31 EPS past 5Y12.18% ROI9.37% 52W High-35.49% Beta0.85
Dividend TTM6.52 (1.78%) Quick Ratio- Sales past 5Y13.24% Gross Margin- 52W Low1.04% ATR (14)10.29
Dividend Ex-DateDec 05, 2024 Current Ratio1.50 EPS Y/Y TTM7.55% Oper. Margin5.29% RSI (14)28.86 Volatility2.68% 2.51%
Employees104900 Debt/Eq0.62 Sales Y/Y TTM3.20% Profit Margin3.69% Recom1.71 Target Price499.39
Option/ShortYes / Yes LT Debt/Eq0.56 EPS Q/Q-20.03% Payout23.47% Rel Volume1.79 Prev Close366.48
Sales Surprise2.88% EPS Surprise-13.33% Sales Q/Q5.36% EarningsOct 17 BMO Avg Volume1.92M Price365.96
SMA20-5.98% SMA50-11.09% SMA200-26.61% Trades Volume3,438,136 Change-0.14%
Date Action Analyst Rating Change Price Target Change
Oct-18-24Downgrade Argus Buy → Hold
Jul-18-24Downgrade BofA Securities Buy → Neutral $646 → $530
Jun-24-24Initiated Morgan Stanley Overweight $643
May-30-24Initiated Robert W. Baird Outperform $649
Mar-06-24Initiated Barclays Overweight $584
Jul-12-23Downgrade Wolfe Research Outperform → Peer Perform
Apr-27-23Upgrade Morgan Stanley Equal-Weight → Overweight $500 → $571
Apr-21-23Initiated Cantor Fitzgerald Overweight $547
Mar-28-23Upgrade RBC Capital Mkts Sector Perform → Outperform $523 → $572
Sep-09-22Upgrade BofA Securities Neutral → Buy $535 → $575
Dec-20-24 04:57PM
Dec-18-24 12:07PM
Dec-17-24 08:54PM
11:24AM
Dec-11-24 10:54PM
12:19PM Loading…
12:19PM
11:40AM
Dec-10-24 09:47AM
Dec-06-24 02:03PM
12:35PM
Dec-05-24 05:10PM
Dec-04-24 01:18PM
Nov-30-24 07:15PM
Nov-26-24 07:30AM
Nov-19-24 06:15AM
11:55AM Loading…
Nov-18-24 11:55AM
Nov-06-24 09:45AM
Nov-05-24 04:05PM
Nov-04-24 09:00AM
05:30AM
Oct-28-24 03:51PM
Oct-25-24 10:26AM
Oct-23-24 10:00AM
Oct-19-24 07:00AM
Oct-18-24 04:59PM
12:57PM
03:02AM
01:06AM
01:02AM
12:00AM
07:24PM Loading…
Oct-17-24 07:24PM
07:17PM
07:17PM
05:10PM
03:33PM
03:04PM
01:56PM
01:45PM
01:09PM
12:54PM
12:38PM
12:15PM
11:37AM
11:35AM
10:51AM
10:35AM
09:58AM
09:30AM
08:36AM
07:10AM
06:06AM
06:00AM
Oct-16-24 12:10PM
Oct-14-24 09:15AM
08:27AM
Oct-12-24 07:41AM
Oct-10-24 10:00AM
Oct-07-24 03:22PM
10:59AM
08:00AM
06:17AM
Oct-04-24 01:22PM
Oct-02-24 01:00PM
Sep-30-24 10:45AM
Sep-26-24 10:20AM
Sep-25-24 01:49PM
Sep-13-24 05:08AM
Sep-05-24 12:58PM
07:59AM
Aug-29-24 03:01AM
Aug-25-24 04:22PM
Aug-22-24 03:09PM
Aug-20-24 04:40PM
Aug-19-24 08:39AM
Aug-16-24 11:30AM
Aug-13-24 07:08PM
Aug-12-24 10:00AM
Aug-06-24 11:30PM
Aug-02-24 07:43AM
Jul-31-24 05:00PM
Jul-29-24 03:29PM
Jul-26-24 10:40PM
Jul-25-24 07:00AM
Jul-23-24 12:23AM
Jul-19-24 12:33PM
Jul-18-24 02:58AM
01:01AM
Jul-17-24 01:33PM
12:00PM
10:52AM
10:42AM
10:16AM
10:02AM
09:30AM
07:10AM
06:18AM
06:17AM
06:06AM
06:00AM
Jul-16-24 09:40AM
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kendrick Charles Morgan JREVP & President, CommercialOct 18 '24Sale432.147,4173,205,1828,423Oct 18 05:21 PM
Kendrick Charles Morgan JRDirectorOct 18 '24Proposed Sale432.287,4173,206,221Oct 18 01:48 PM
PERU RAMIRO GDirectorAug 05 '24Sale531.52753400,2358,744Aug 06 05:23 PM
RAMIRO G PERUDirectorAug 05 '24Proposed Sale531.52753400,235Aug 05 04:14 PM
BOUDREAUX GAILPresident and CEOJul 22 '24Sale500.9834,00017,033,395126,709Jul 23 05:02 PM
Dixon Robert L JRDirectorJul 19 '24Sale506.76305154,5629,721Jul 22 04:30 PM
Norwood Felicia FEVP & President,Gov Health BenApr 23 '24Option Exercise238.275,4731,304,05245,571Apr 25 05:05 PM
Norwood Felicia FEVP & President,Gov Health BenApr 24 '24Option Exercise238.272,043486,78633,503Apr 25 05:05 PM
Norwood Felicia FEVP & President,Gov Health BenApr 23 '24Sale533.7414,1117,531,56531,460Apr 25 05:05 PM
Norwood Felicia FEVP & President,Gov Health BenApr 24 '24Sale532.446,1993,300,59027,304Apr 25 05:05 PM
Kendrick Charles Morgan JREVP & President, CommercialMar 08 '24Sale500.462,4321,217,11915,840Mar 12 04:26 PM
Penczek Ronald WCAO & ControllerMar 06 '24Sale504.58916462,1951,764Mar 08 04:16 PM
Haytaian Peter DEVP & Pres Carelon & CarelonRxMar 04 '24Option Exercise166.9715,0002,504,55039,982Mar 05 04:24 PM
Haytaian Peter DEVP & Pres Carelon & CarelonRxMar 04 '24Sale500.1821,09510,551,29718,887Mar 05 04:24 PM
PERU RAMIRO GDirectorFeb 07 '24Sale500.00753376,5009,109Feb 09 04:22 PM